PubRank

Pierre Bedossa

Author PubWeight™ 150.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2007 3.61
2 Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006 3.06
3 Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 2009 2.97
4 A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003 2.82
5 Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 2005 2.64
6 Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study). J Hepatol 2010 2.57
7 Fibrosis in human adipose tissue: composition, distribution, and link with lipid metabolism and fat mass loss. Diabetes 2010 2.46
8 Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis. J Hepatol 2010 2.43
9 Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011 2.28
10 Adipose tissue transcriptomic signature highlights the pathological relevance of extracellular matrix in human obesity. Genome Biol 2008 2.22
11 Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2008 2.19
12 Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology 2009 2.00
13 Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up. Hepatology 2006 1.97
14 IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C. J Hepatol 2011 1.97
15 Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C. Gastroenterology 2008 1.95
16 Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. J Hepatol 2011 1.94
17 A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver. J Hepatol 2013 1.84
18 CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur J Immunol 2011 1.81
19 Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. Gastroenterology 2009 1.79
20 Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. Gastroenterology 2011 1.71
21 Risk factors of fibrosis in alcohol-induced liver disease. Hepatology 2002 1.70
22 A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009 1.70
23 Liver biopsy: the best, not the gold standard. J Hepatol 2008 1.65
24 Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 2002 1.54
25 C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients. J Hepatol 2011 1.54
26 Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases. Hepatology 2005 1.54
27 Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005 1.52
28 Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 2008 1.51
29 Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome. Gut 2012 1.50
30 Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 2005 1.48
31 Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. J Clin Endocrinol Metab 2010 1.44
32 In vivo hepatic endoplasmic reticulum stress in patients with chronic hepatitis C. J Pathol 2010 1.41
33 Long-term results of renal transplantation using kidneys harvested from non-heartbeating donors: a 15-year experience. J Urol 2003 1.39
34 Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008 1.34
35 A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis. Hepatology 2012 1.29
36 Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004 1.26
37 Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas. Hum Pathol 2006 1.26
38 High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study. J Hepatol 2009 1.25
39 Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy. Hepatology 2012 1.24
40 Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy. Gut 2006 1.24
41 [Standards, Options and Recommendations for the management of patient with carcinoma of unknown primary site]. Bull Cancer 2002 1.24
42 Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007 1.21
43 Overexpression of the oxygen sensors PHD-1, PHD-2, PHD-3, and FIH Is associated with tumor aggressiveness in pancreatic endocrine tumors. Clin Cancer Res 2008 1.19
44 Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 2011 1.14
45 Hepatic steatosis in HIV-HCV coinfected patients: analysis of risk factors. AIDS 2006 1.13
46 Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity. J Hepatol 2012 1.11
47 Genetics, genomics, and proteomics: implications for the diagnosis and the treatment of chronic hepatitis C. Semin Liver Dis 2007 1.08
48 Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol 2012 1.05
49 Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg 2005 1.04
50 Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas. J Hepatol 2009 1.04
51 Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2008 1.04
52 Direct comparison of diagnostic performance of transient elastography in patients with chronic hepatitis B and chronic hepatitis C. Liver Int 2011 1.04
53 Sporadic desmoid tumor. An exceptional cause of cystic pancreatic lesion. JOP 2008 1.04
54 Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors. Mod Pathol 2008 1.02
55 Gastric inflammatory myofibroblastic tumors in children: an unpredictable course. J Pediatr Gastroenterol Nutr 2002 1.02
56 Serum alpha-foetoprotein level predicts treatment outcome in chronic hepatitis C. Antivir Ther 2007 1.01
57 Reversibility of hepatitis C virus-related cirrhosis. Hum Pathol 2004 1.00
58 Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 2006 0.99
59 Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors. Gastroenterology 2006 0.99
60 A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003 0.98
61 Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status. J Hepatol 2009 0.96
62 How to measure the diagnostic accuracy of noninvasive liver fibrosis indices: the area under the ROC curve revisited. Clin Chem 2008 0.96
63 Response to pegylated interferon alfa-2a and ribavirin in chronic hepatitis C genotype 4. J Med Virol 2009 0.95
64 p63 gene expression study and early bladder carcinogenesis. Urology 2007 0.95
65 Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS One 2012 0.94
66 Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol 2010 0.94
67 Virological response at 4 weeks to predict outcome of hepatitis C treatment with pegylated interferon and ribavirin. Antivir Ther 2009 0.93
68 How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs. liver biopsy? Liver Int 2011 0.92
69 Association of adipose tissue and liver fibrosis with tissue stiffness in morbid obesity: links with diabetes and BMI loss after gastric bypass. J Clin Endocrinol Metab 2014 0.92
70 Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C. J Virol 2014 0.91
71 The diagnostic accuracy of Fibroscan for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response. J Hepatol 2013 0.91
72 Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors. Clin Infect Dis 2008 0.90
73 Direct and indirect evidence for the reversibility of cirrhosis. Hum Pathol 2006 0.90
74 Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients. Clin Cancer Res 2012 0.90
75 Proteomic assessment of markers for malignancy in the mucus of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 2012 0.90
76 Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index. Am J Pathol 2003 0.89
77 Changes in autophagic response in patients with chronic hepatitis C virus infection. Am J Pathol 2011 0.89
78 Aberrant expression of OX1 receptors for orexins in colon cancers and liver metastases: an openable gate to apoptosis. Cancer Res 2011 0.87
79 Alagille syndrome in adult patients: it is never too late. Am J Kidney Dis 2007 0.87
80 Imaging mass spectrometry reveals modified forms of histone H4 as new biomarkers of microvascular invasion in hepatocellular carcinomas. Hepatology 2013 0.86
81 Predictors of tumor response after preoperative chemoradiotherapy for rectal adenocarcinomas. Hum Pathol 2011 0.86
82 CD10 expression in pancreatic endocrine tumors: correlation with prognostic factors and survival. Hum Pathol 2006 0.86
83 [Pancreatic perivascular epithelioid cell tumor (PEComa)]. Ann Pathol 2008 0.86
84 Algorithm for immediate cytologic diagnosis of hepatic tumors. AJR Am J Roentgenol 2008 0.85
85 Gene expression study of Aurora-A reveals implication during bladder carcinogenesis and increasing values in invasive urothelial cancer. Urology 2008 0.85
86 The role of replicative senescence in chronic allograft nephropathy. Hum Pathol 2003 0.85
87 The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO): a case-control study. Am J Surg Pathol 2009 0.85
88 Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Am J Surg Pathol 2009 0.84
89 Fighting the bushfire in HCC trials. J Hepatol 2011 0.84
90 Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin. Gastroenterology 2006 0.84
91 Hypoxia pathways and cellular stress activate pancreatic stellate cells: development of an organotypic culture model of thick slices of normal human pancreas. PLoS One 2013 0.84
92 Pathology of the liver sinusoids. Histopathology 2014 0.83
93 Imaging mass spectrometry provides fingerprints for distinguishing hepatocellular carcinoma from cirrhosis. J Proteome Res 2011 0.83
94 Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors. Endocr Relat Cancer 2010 0.83
95 Immunoglobulin G4 immunostaining of gastric, duodenal, or colonic biopsies is not helpful for the diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol 2011 0.82
96 [Sclerosing mesenteritis: can it be a IgG4 dysimmune disease?]. Ann Pathol 2009 0.82
97 Pathological prognostic factors in locally advanced rectal carcinoma after neoadjuvant radiochemotherapy: analysis of 113 cases. Histopathology 2014 0.81
98 Solid adenoma with exclusive hepatocellular differentiation: a new variant among pancreatic benign neoplasms? Virchows Arch 2002 0.81
99 The expression of the hypoxia markers CA9 and CXCR4 is correlated with survival in patients with neuroendocrine tumours of the ileum. Neuroendocrinology 2011 0.80
100 A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses. Infect Agent Cancer 2012 0.80
101 Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J Immunol 2002 0.80
102 Measurement of telomere length on tissue sections using quantitative fluorescence in situ hybridization (Q-FISH). J Pathol 2003 0.80
103 The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management. Nephrol Dial Transplant 2003 0.79
104 Significant gene expression differences in histologically "Normal" liver biopsies: Implications for control tissue. Hepatology 2008 0.79
105 Signet-ring cell change in acute erosive gastropathy. Am J Surg Pathol 2004 0.79
106 Respective roles of porto-septal fibrosis and centrilobular fibrosis in alcoholic liver disease. J Pathol 2003 0.79
107 High serum level of alpha-fetoprotein in focal nodular hyperplasia of the liver. Pathol Int 2011 0.79
108 Quantitative RT-PCR in cirrhotic nodules reveals gene expression changes associated with liver carcinogenesis. J Pathol 2003 0.79
109 Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy. J Pathol 2014 0.79
110 Global proteomic analysis of microdissected cirrhotic nodules reveals significant biomarkers associated with clonal expansion. Lab Invest 2006 0.79
111 Harmony in liver fibrosis... J Hepatol 2010 0.78
112 [Non invasive markers using for the assessment of fibrosis in hepatitis C]. Gastroenterol Clin Biol 2007 0.78
113 Primary biliary cirrhosis: proposal for a new simple histological scoring system. Liver Int 2014 0.78
114 In the new area of noninvasive markers of hepatocellular carcinoma. J Hepatol 2006 0.78
115 Serum alpha-fetoprotein predicts virologic response to hepatitis C treatment in HIV coinfected patients. AIDS 2008 0.78
116 Gly388Arg FGFR4 Polymorphism Is Not Predictive of Everolimus Efficacy in Well-Differentiated Digestive Neuroendocrine Tumors. Neuroendocrinology 2015 0.77
117 Plasma proteome to look for diagnostic biomarkers of early bacterial sepsis after liver transplantation: a preliminary study. Anesthesiology 2010 0.77
118 Pathology analysis reveals that dysplastic pancreatic ductal lesions are frequent in patients with hereditary pancreatitis. Clin Gastroenterol Hepatol 2009 0.77
119 Diagnosis of sinusoidal obstruction syndrome by positron emission tomography/computed tomography: report of two cases treated by defibrotide. Hepatology 2014 0.77
120 Inhibitors of swelling-activated chloride channels increase infarct size and apoptosis in rabbit myocardium. Fundam Clin Pharmacol 2003 0.77
121 Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats. J Pharmacol Exp Ther 2007 0.77
122 Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transplant 2004 0.77
123 N-butyl-2-cyanoacrylate in gastric varices: a cause for recurrent sepsis. Am J Gastroenterol 2013 0.76
124 Liver fibrosis: screening is not staging. J Hepatol 2009 0.76
125 [Pathology of cholangiocarcinoma]. Ann Pathol 2010 0.76
126 Does early antiretroviral treatment prevent liver fibrosis in HIV/HCV-coinfected patients? J Acquir Immune Defic Syndr 2009 0.76
127 SCG10 expression on activation of hepatic stellate cells promotes cell motility through interference with microtubules. Am J Pathol 2010 0.76
128 Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry. Proteomics 2014 0.76
129 Fatal bile duct necrosis: a rare complication of transcatheter arterial chemoembolization in a patient with endocrine hepatic metastasis. Case Rep Gastroenterol 2008 0.76
130 [A case of epithelioid hemangioma of the spine]. Ann Pathol 2011 0.75
131 [A tumour not so clear]. Ann Pathol 2002 0.75
132 Impact of different combined preservation modalities on warm ischemic kidneys: effect on oxidative stress, hydrostatic perfusion characteristics and tissue damage. Urol Res 2002 0.75
133 Somatostatin receptor subtype 2 expression and somatostatin receptor scintigraphy positivity in pancreatic serous cystadenomas. Pancreas 2015 0.75
134 A clear cell malignant gastrinoma of the pancreas with cytoplasmic accumulation of lipid droplets. Virchows Arch 2005 0.75
135 Role of hepatic HCV-RNA level on the severity of chronic hepatitis C and response to antiviral therapy. J Clin Virol 2011 0.75
136 A new feature of the MYH9-related syndrome: chronic transaminase elevation. Hepatology 2012 0.75
137 Noninvasive diagnosis of nonalcoholic steatohepatitis disease based on clinical decision support system. Stud Health Technol Inform 2013 0.75
138 [A rare cervical tumor]. Ann Pathol 2008 0.75
139 [Clinical practice guidelines: Standards, Options and Recommendations for the diagnosis of carcinomas of unknown primary site]. Bull Cancer 2003 0.75
140 Use of laser capture microdissection for clonal analysis. Methods Enzymol 2002 0.75
141 [Post-cholecystectomy amputation neuroma of the common bile duct with obstructive jaundice]. Gastroenterol Clin Biol 2005 0.75